• Shingrix Vaccine to Prevent Shingles - September 2024 Update

• New ASCIA Clinical Care Standard for Inborn Errors of Immunity (IEI)/ Primary Immunodeficiencies (PID) 

• New ASCIA Sjögren’s Disease FAQ for patients and carers

• New Activity Based Funding for subcutaneous immunoglobulin (SCIg) therapy

• New treatment for severe lupus listed on PBS 1 July 2024

• New Australian hereditary angioedema (HAE) publication

• ASCIA Quicklinks - developed to improve access to ASCIA website information using QR codes

This news item was issued on 7 August and updated on 18 September 2024 by Jill Smith, CEO of ASCIA, the peak professional body for clinical immunology and allergy in Australia and New Zealand.